# Proteomics and Stem Cell Therapy as a New Vascularization Strategy

> **NCT02802852** · NA · COMPLETED · sponsor: **University of Illinois at Chicago** · enrollment: 9 (actual)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **DEVICE:** Pneumatic calf compression
- **DRUG:** Filgrastim

## Key facts

- **NCT ID:** NCT02802852
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-03
- **Final completion:** 2019-03
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2021-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02802852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02802852, "Proteomics and Stem Cell Therapy as a New Vascularization Strategy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02802852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*